Key Points
- Encompass Health EVP John Patrick Darby sold 4,858 shares at an average price of $121.09, generating approximately $588,255. Following the transaction, he retained 75,041 shares; he also sold 8,906 shares earlier in August.
- Encompass Health reported quarterly EPS of $1.55, beating estimates of $1.48, while revenue reached $1.60 billion and rose 9.6% year over year. The company’s FY 2026 EPS guidance is $6.02–$6.25.
- The company increased its quarterly dividend from $0.19 to $0.21 per share, implying an annualized dividend of $0.84 and a 0.7% yield. Analysts maintain a consensus “Buy” rating with an average price target of $148.71.
Encompass Health Corporation (NYSE:EHC - Get Free Report) EVP John Patrick Darby sold 4,858 shares of the business's stock in a transaction on Monday, August 31st. The shares were sold at an average price of $121.09, for a total transaction of $588,255.22. Following the sale, the executive vice president directly owned 75,041 shares of the company's stock, valued at $9,086,714.69. This represents a 6.08% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.
John Patrick Darby also recently made the following trade(s):
- On Monday, August 10th, John Patrick Darby sold 8,906 shares of Encompass Health stock. The stock was sold at an average price of $125.95, for a total value of $1,121,710.70.
Encompass Health Price Performance
EHC stock opened at $122.23 on Wednesday. The company has a market cap of $12.06 billion, a PE ratio of 19.91, a price-to-earnings-growth ratio of 2.43 and a beta of 0.74. The company has a current ratio of 1.19, a quick ratio of 1.19 and a debt-to-equity ratio of 0.76. The stock has a 50-day moving average price of $114.08 and a two-hundred day moving average price of $107.33. Encompass Health Corporation has a 12-month low of $92.77 and a 12-month high of $127.99.
Encompass Health (NYSE:EHC - Get Free Report) last released its quarterly earnings data on Wednesday, August 5th. The company reported $1.55 EPS for the quarter, topping analysts' consensus estimates of $1.48 by $0.07. The company had revenue of $1.60 billion for the quarter, compared to the consensus estimate of $1.57 billion. Encompass Health had a return on equity of 18.08% and a net margin of 10.01%.The company's quarterly revenue was up 9.6% compared to the same quarter last year. During the same period last year, the business posted $1.40 EPS. Encompass Health has set its FY 2026 guidance at 6.020-6.250 EPS. As a group, research analysts predict that Encompass Health Corporation will post 6.08 EPS for the current year.
Encompass Health Increases Dividend
The firm also recently declared a quarterly dividend, which will be paid on Thursday, October 15th. Investors of record on Thursday, October 1st will be issued a $0.21 dividend. The ex-dividend date is Thursday, October 1st. This is a positive change from Encompass Health's previous quarterly dividend of $0.19. This represents a $0.84 annualized dividend and a yield of 0.7%. Encompass Health's payout ratio is 12.38%.
Institutional Trading of Encompass Health
Large investors have recently bought and sold shares of the company. California State Teachers Retirement System raised its stake in shares of Encompass Health by 9,758.8% during the second quarter. California State Teachers Retirement System now owns 11,605,197 shares of the company's stock valued at $1,173,053,000 after purchasing an additional 11,487,483 shares during the period. BlackRock Inc. purchased a new position in shares of Encompass Health in the second quarter valued at $1,059,762,000. Price T Rowe Associates Inc. MD grew its holdings in Encompass Health by 24.6% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 4,805,413 shares of the company's stock valued at $510,047,000 after purchasing an additional 948,202 shares in the last quarter. Northwestern Mutual Wealth Management Co. increased its stake in Encompass Health by 3,059,159.7% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 3,793,482 shares of the company's stock worth $402,640,000 after buying an additional 3,793,358 shares during the period. Finally, Wellington Management Group LLP increased its stake in Encompass Health by 21.7% during the 4th quarter. Wellington Management Group LLP now owns 3,384,877 shares of the company's stock worth $359,271,000 after buying an additional 603,472 shares during the period. Institutional investors and hedge funds own 97.25% of the company's stock.
Analyst Upgrades and Downgrades
EHC has been the subject of several research reports. Weiss Ratings upgraded shares of Encompass Health from a "hold (c+)" rating to a "buy (b-)" rating in a research note on Wednesday, August 12th. Barclays raised their target price on shares of Encompass Health from $140.00 to $144.00 and gave the company an "overweight" rating in a research note on Thursday, August 6th. Wall Street Zen raised shares of Encompass Health from a "hold" rating to a "buy" rating in a research report on Sunday, August 16th. Truist Financial increased their price target on Encompass Health from $140.00 to $150.00 and gave the company a "buy" rating in a report on Friday, August 7th. Finally, UBS Group raised their price objective on Encompass Health from $150.00 to $155.00 and gave the company a "buy" rating in a research report on Friday, August 7th. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat.com, Encompass Health presently has a consensus rating of "Buy" and a consensus price target of $148.71.
Check Out Our Latest Report on Encompass Health
About Encompass Health
(
Get Free Report)
Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.
Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
